Literature DB >> 28287861

Association of Skin Intrinsic Fluorescence with Retinal Microvascular Complications of Long Term Type 1 Diabetes in the Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Barbara E K Klein1, Kayla L Horak1, John D Maynard2, Kristine E Lee1, Ronald Klein1.   

Abstract

OBJECTIVE: To determine the association between skin intrinsic fluorescence (SIF), a noninvasive measure of advanced glycation endproducts and oxidative stress in skin, and retinal microvascular complications of long duration type 1 diabetes, proliferative diabetic retinopathy (PDR) and macular edema.
METHODS: A cross-sectional cohort study of persons with type 1 diabetes in the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) who participated in a 32-year follow-up examination in 2012-2014. Subjects underwent a physical examination, answered a health questionnaire, and had fundus photographs taken. SIF was measured on the underside of the left forearm near the elbow with the SCOUT DS® skin fluorescence spectrometer. Two representative SIF measures were used for these analyses: SIF01 excited by an LED centered at 375 nm with correction factors Kx = 0.6 and Km = 0.2 and SIF15 excited by an LED centered at 456 nm with correction factors Kx = 0.4 and Km = 0.9.
RESULTS: The 414 participants had mean diabetes duration of 42.2 years (standard deviation 6.8 years, range 32.9-67.9 years). PDR was statistically significantly associated (p < 0.05) with both SIF measures in multivariate models including other relevant factors (odds ratio [OR] = 1.17 for SIF01 and 1.20 for SIF15).
CONCLUSION: Skin intrinsic fluorescence measures are independently associated with PDR in the WESDR. Incidence information is needed to evaluate whether there is a causal relationship.

Entities:  

Keywords:  Advanced glycation endproducts; macular edema; nephropathy; proliferative diabetic retinopathy; skin intrinsic fluorescence

Mesh:

Year:  2017        PMID: 28287861      PMCID: PMC5994766          DOI: 10.1080/09286586.2016.1269934

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  27 in total

1.  Noninvasive, optical detection of diabetes: model studies with porcine skin.

Authors:  E Hull; M Ediger; A Unione; E Deemer; M Stroman; J Baynes
Journal:  Opt Express       Date:  2004-09-20       Impact factor: 3.894

2.  The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group.

Authors: 
Journal:  Prev Med       Date:  1976-06       Impact factor: 4.018

3.  Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes.

Authors:  Baqiyyah Conway; Daniel Edmundowicz; Nathaniel Matter; John Maynard; Trevor Orchard
Journal:  Diabetes Technol Ther       Date:  2010-05       Impact factor: 6.118

4.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

5.  Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.

Authors:  V M Monnier; O Bautista; D Kenny; D R Sell; J Fogarty; W Dahms; P A Cleary; J Lachin; S Genuth
Journal:  Diabetes       Date:  1999-04       Impact factor: 9.461

6.  Prevalence of diabetes mellitus in southern Wisconsin.

Authors:  R Klein; B E Klein; S E Moss; D L DeMets; I Kaufman; P S Voss
Journal:  Am J Epidemiol       Date:  1984-01       Impact factor: 4.897

7.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.

Authors:  R Klein; B E Klein; S E Moss; K J Cruickshanks
Journal:  Ophthalmology       Date:  1998-10       Impact factor: 12.079

8.  Noninvasive skin fluorescence spectroscopy is comparable to hemoglobin A1c and fasting plasma glucose for detection of abnormal glucose tolerance.

Authors:  Byron P Olson; Nathaniel I Matter; Marwood N Ediger; Edward L Hull; John D Maynard
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

9.  The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study.

Authors:  Trevor J Orchard; Timothy J Lyons; Patricia A Cleary; Barbara H Braffett; John Maynard; Catherine Cowie; Rose A Gubitosi-Klug; Jeff Way; Karen Anderson; Annette Barnie; Stephan Villavicencio
Journal:  Diabetes Care       Date:  2013-06-28       Impact factor: 19.112

10.  Advanced glycation end products: Key players in skin aging?

Authors:  Paraskevi Gkogkolou; Markus Böhm
Journal:  Dermatoendocrinol       Date:  2012-07-01
View more
  5 in total

1.  Skin Intrinsic Fluorescence and Selected Measures of Visual Function and aging in Older Adults.

Authors:  Barbara E K Klein; Kristine E Lee; John D Maynard; Chris A Johnson; Lorraine Danforth; Ronald Klein
Journal:  Ophthalmic Epidemiol       Date:  2019-04-27       Impact factor: 1.648

Review 2.  Discoveries from the study of longstanding type 1 diabetes.

Authors:  Bruce A Perkins; Leif Erik Lovblom; Sebastien O Lanctôt; Krista Lamb; David Z I Cherney
Journal:  Diabetologia       Date:  2021-03-04       Impact factor: 10.122

3.  Predictors of Change in Skin Intrinsic Fluorescence in Type 1 Diabetes: The Epidemiology of Diabetes Complications Study.

Authors:  Erin L Tomaszewski; Trevor J Orchard; Marquis S Hawkins; Rebecca B N Conway; Jeanine M Buchanich; John Maynard; Thomas Songer; Tina Costacou
Journal:  J Diabetes Sci Technol       Date:  2021-05-15

4.  Transthyretin Upregulates Long Non-Coding RNA MEG3 by Affecting PABPC1 in Diabetic Retinopathy.

Authors:  Guangming Fan; Yu Gu; Jiaojiao Zhang; Yu Xin; Jun Shao; Francesca Giampieri; Maurizio Battino
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

5.  Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations.

Authors:  Yousof Taghavi; Gholamhossein Hassanshahi; Nicholas G Kounis; Ioanna Koniari; Hossein Khorramdelazad
Journal:  J Cell Commun Signal       Date:  2019-01-03       Impact factor: 5.908

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.